Aspicio Therapeutics reported raising $200,000 in an initial SEC Form D filing, from an offering of $200,000
Round Type
Pre-Seed
PennsylvaniaHealthcareQuick answer
Aspicio Therapeutics raised $200,000 in a Pre-Seed round, dated July 16, 2026. Aspicio Therapeutics is based in Pennsylvania, United States.
- How much did Aspicio Therapeutics raise?
- Aspicio Therapeutics raised $200,000 in a Pre-Seed round on July 16, 2026.
- Where is Aspicio Therapeutics based and how big is it?
- Aspicio Therapeutics is based in Pennsylvania, United States.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Aspicio Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Endovia Health Sciences, Inc. raised $108K (Funding Round) on August 28, 2026.
- DexCare raised $13M on August 28, 2026.
- Tenon Medical raised $3M (Post-IPO Equity) on August 28, 2026.
- Quoin Pharmaceuticals Ltd. raised $50M (Post-IPO Equity) on August 28, 2026.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- Healthcare Shares P.B.C raised $1.5M on August 24, 2026.
Who to call at Aspicio Therapeutics, and when
A new round usually means Aspicio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aspicio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aspicio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aspicio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aspicio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Aspicio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.